We use cookies for a better user experience. Read our Privacy Policy

I Agree

Human Growth Hormone Market

Human Growth Hormone Market (Route of Administration- Intravenous, Subcutaneous, Intramuscular, Oral; Distribution Channel– Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Clinics; Indication- Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Other Indications) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026

Human growth hormone is responsible for growth and regeneration among humans and also stimulates cell reproduction. However, deficiency of growth hormone is constantly on the rise. Advancements in technology including development of recombinant human growth hormone by the major players is boosting the market growth. Also, the leading companies are focusing on increasing their production capacity in order to increase supply in the rural areas.

As per the latest report by Transparency Market Research (TMR), the global market for human growth hormone is likely to see strong growth in the coming years. The market is estimated to increase to 6.2% CAGR. The global market for human growth hormone is also estimated to generate US$ 5,261.5 million revenue by 2026 end.

Global Human Growth Hormone Market

Subcutaneous as Route of Administration is likely to Witness Substantial Growth

Among various route of administration, subcutaneous as the route of administration is likely to witness substantial growth between 2017 and 2026. Subcutaneous as the route of administration is estimated to surpass US$ 1,600 million revenue by 2026 end. The preference for the subcutaneous method is increasing as it leads to the significant rise in growth rates and low incidence of antibody development. Moreover, subcutaneous route is highly preferred for chronic growth hormone therapy.

Hospital Pharmacy to be the Largest Distribution Channel in the Global Market for Human Growth Hormone  

Compared to the various distribution channels, hospital pharmacy is likely to emerge as one of the largest distribution channels. By the end of the forecast period, hospital pharmacy is projected to bring in close to US$ 2,200 million revenue. Owing to the high cost of human growth hormone drugs, a lot of hospital pharmacies are distributing drugs. Also, high investment for development of advanced healthcare centers and hospitals by governments in various countries is also driving the distribution of growth hormone drugs through hospital pharmacy.

Growth Hormone Deficiency to Witness Highest Growth based on Indication

Growth hormone deficiency is likely to account for the largest market share in terms of value. Towards the end of 2026, growth hormone deficiency is estimated to create an incremental opportunity of more than US$ 1,100 million between 2017 and 2026. Pituitary tumors, metabolic abnormalities, and skeletal abnormalities are some of the factors resulting in the rise of growth hormone deficiency. Adults with growth hormone deficiency are also increasingly taking growth hormone injections as it protects them from increased muscle mass, fractures, and also reduces the risk of heart diseases.

North America to Emerge as the Largest Region in the Global Market for Human Growth Hormone

North America is likely to emerge as the largest region between 2017 and 2026. Presence of the major market players and commercialization of growth hormone by the U.S. Food and Drugs Administration (FDA) are driving the market growth. Meanwhile, Asia Pacific Excluding Japan (APEJ) is also expected to witness the fastest growth in the coming years. India, China, and Australia are contributing towards the growth in the region. Moreover, increasing number of people suffering from growth hormone deficiency also presents an opportunity for the leading companies in APEJ region.

Key Competitors in the Global Market for Human Growth Hormone

Merck KGaA, Pfizer Inc., Eli Lilly and Company, Novartis AG, Novo Nordisk A/S, Anhui Anke Biotechnology (Group) Co., Ltd, Biopartners GmbH, Ipsen S.A, GeneScience Pharmaceuticals Co., Ltd., and Roche Holdings, Inc., are some of the major companies operating in the global market for human growth hormone.

Escalating Cases of Chronic Diseases to Accelerate the Growth Opportunities across the Human Growth Hormone Market

The human growth hormone market is estimated to gain extensive growth opportunities across the assessment period of 2017-2026 on the back of the rise in the awareness about the effectiveness of growth hormones and the increasing prevalence of chronic diseases.

  • The human growth hormone is a type of peptide hormone whose function is the production of cells, growth stimulation, and cell regeneration in the body. It has a significant role in the development of the human body. The overwhelming advantages of human growth hormones will bring immense growth prospects across the forecast period of 2017-2026.
  • The growing prevalence of human growth disorders has led to an increase in awareness about the importance of treatment among a large chunk of the global populace, which will eventually help in increasing the growth of the human growth hormone market substantially.
  • Robust research and development activities play a vital role in the growth of the human growth hormone market. The players in the human growth hormone market invest heavily in these activities for exploring novel formulations that aid in boosting their revenues. The players are also involved in expansion activities which further boost the growth opportunities across the human growth hormone market.
  • The initiatives undertaken by various government and non-government organizations to spread the information about growth hormone deficiencies have helped the human growth hormone market to accelerate its growth at a rapid pace. All these aspects will prove to be vital growth contributors during the forecast period of 2017-2026.
  • Online pharmacies will further propel the growth of the human growth hormone market as retail and medical stores have been hit hard by the novel coronavirus pandemic. Even though pharmacies were allowed to function during the strict lockdown enforcements, the unwillingness of the people to step out due to the fear of transmission boosted the demand for online pharmacies greatly.
Human Growth Hormone Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

1. Global Economic Outlook

2. Global Human Growth Hormone Market - Executive Summary

3. Global Human Growth Hormone Market Overview
     3.1. Introduction
            3.1.1. Global Human Growth Hormone Market Taxonomy
            3.1.2. Global Human Growth Hormone Market Definition
     3.2. Global Human Growth Hormone Market Size (US$ Mn) and Forecast, 2012-2026
            3.2.1. Global Human Growth Hormone Market Y-o-Y Growth
     3.3. Global Human Growth Hormone Market Dynamics
     3.4. Supply Chain
     3.5. Cost Structure
     3.6. Pricing Analysis 
     3.7. PESTLE Analysis
     3.8. List of Distributors
     3.9. Key Participants Market Presence (Intensity Map) By Region

4. Global Human Growth Hormone Market Analysis and Forecast 2012-2026 
     4.1. Global Human Growth Hormone Market Size and Forecast By Route of Administration, 2012-2026
            4.1.1. Intravenous Market Size and Forecast, 2012-2026
                     4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                     4.1.1.2. Market Share Comparison, By Region
                     4.1.1.3. Y-o-Y growth Comparison, By Region
            4.1.2. Subcutaneous Market Size and Forecast, 2012-2026
                     4.1.2.1. Revenue (US$ Mn) Comparison, By Region
                     4.1.2.2. Market Share Comparison, By Region
                     4.1.2.3. Y-o-Y growth Comparison, By Region
            4.1.3. Intramuscular Market Size and Forecast, 2012-2026
                     4.1.3.1. Revenue (US$ Mn) Comparison, By Region
                     4.1.3.2. Market Share Comparison, By Region
                     4.1.3.3. Y-o-Y growth Comparison, By Region
            4.1.4. Oral Market Size and Forecast, 2012-2026
                     4.1.4.1. Revenue (US$ Mn) Comparison, By Region
                     4.1.4.2. Market Share Comparison, By Region
                     4.1.4.3. Y-o-Y growth Comparison, By Region
     4.2. Global Human Growth Hormone Market Size and Forecast By Distribution Channel, 2012-2026
            4.2.1. Hospital Pharmacy Market Size and Forecast, 2012-2026
                     4.2.1.1. Revenue (US$ Mn) Comparison, By Region
                     4.2.1.2. Market Share Comparison, By Region
                     4.2.1.3. Y-o-Y growth Comparison, By Region
            4.2.2. Retail Pharmacy Market Size and Forecast, 2012-2026
                     4.2.2.1. Revenue (US$ Mn) Comparison, By Region
                     4.2.2.2. Market Share Comparison, By Region
                     4.2.2.3. Y-o-Y growth Comparison, By Region
            4.2.3. Online Pharmacy Market Size and Forecast, 2012-2026
                     4.2.3.1. Revenue (US$ Mn) Comparison, By Region
                     4.2.3.2. Market Share Comparison, By Region
                     4.2.3.3. Y-o-Y growth Comparison, By Region
            4.2.4. Clinics Market Size and Forecast, 2012-2026
                     4.2.4.1. Revenue (US$ Mn) Comparison, By Region
                     4.2.4.2. Market Share Comparison, By Region
                     4.2.4.3. Y-o-Y growth Comparison, By Region
     4.3. Global Human Growth Hormone Market Size and Forecast By Indication, 2012-2026
            4.3.1. Growth Hormone Deficiency Market Size and Forecast, 2012-2026
                     4.3.1.1. Revenue (US$ Mn) Comparison, By Region
                     4.3.1.2. Market Share Comparison, By Region
                     4.3.1.3. Y-o-Y growth Comparison, By Region
            4.3.2. Turner Syndrome Market Size and Forecast, 2012-2026
                     4.3.2.1. Revenue (US$ Mn) Comparison, By Region
                     4.3.2.2. Market Share Comparison, By Region
                     4.3.2.3. Y-o-Y growth Comparison, By Region
            4.3.3. Idiopathic Short Stature Market Size and Forecast, 2012-2026
                     4.3.3.1. Revenue (US$ Mn) Comparison, By Region
                     4.3.3.2. Market Share Comparison, By Region
                     4.3.3.3. Y-o-Y growth Comparison, By Region
            4.3.4. Prader-Willi Syndrome Market Size and Forecast, 2012-2026
                     4.3.4.1. Revenue (US$ Mn) Comparison, By Region
                     4.3.4.2. Market Share Comparison, By Region
                     4.3.4.3. Y-o-Y growth Comparison, By Region
            4.3.5. Other Indications Market Size and Forecast, 2012-2026
                     4.3.5.1. Revenue (US$ Mn) Comparison, By Region
                     4.3.5.2. Market Share Comparison, By Region
                     4.3.5.3. Y-o-Y growth Comparison, By Region

5. North America Human Growth Hormone Market Size and Forecast, 2012-2026
     5.1. North America Outlook 
     5.2. North America Parent Market Outlook 
     5.3. North America Target Market Outlook 
     5.4. Revenue (US$ Mn) Comparison, By Country 
            5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
            5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
     5.5. Revenue (US$ Mn) Comparison, By Route of Administration 
     5.6. Revenue (US$ Mn) Comparison, By Distribution Channel 
     5.7. Revenue (US$ Mn) Comparison, By Indication 

6. Latin America Human Growth Hormone Market Size and Forecast, 2012-2026
     6.1. Latin America Outlook 
     6.2. Latin America Parent Market Outlook 
     6.3. Latin America Target Market Outlook 
     6.4. Revenue (US$ Mn) Comparison, By Country 
            6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
            6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
            6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
     6.5. Revenue (US$ Mn) Comparison, By Route of Administration 
     6.6. Revenue (US$ Mn) Comparison, By Distribution Channel 
     6.7. Revenue (US$ Mn) Comparison, By Indication 

7. Europe Human Growth Hormone Market Size and Forecast, 2012-2026
     7.1. Europe Outlook 
     7.2. Europe Parent Market Outlook 
     7.3. Europe Target Market Outlook 
     7.4. Revenue (US$ Mn) Comparison, By Country 
            7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
            7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
            7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
            7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
            7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
            7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
     7.5. Revenue (US$ Mn) Comparison, By Route of Administration 
     7.6. Revenue (US$ Mn) Comparison, By Distribution Channel 
     7.7. Revenue (US$ Mn) Comparison, By Indication 

8. Japan Human Growth Hormone Market Size and Forecast, 2012-2026
     8.1. Japan Outlook 
     8.2. Japan Parent Market Outlook 
     8.3. Japan Target Market Outlook 
     8.4. Revenue (US$ Mn) Comparison, By Country 
            8.4.1. Japan  Market Size and Forecast (US$ Mn), 2012-2026
     8.5. Revenue (US$ Mn) Comparison, By Route of Administration 
     8.6. Revenue (US$ Mn) Comparison, By Distribution Channel 
     8.7. Revenue (US$ Mn) Comparison, By Indication 

9. APEJ Human Growth Hormone Market Size and Forecast, 2012-2026
     9.1. APEJ Outlook 
     9.2. APEJ Parent Market Outlook 
     9.3. APEJ Target Market Outlook 
     9.4. Revenue (US$ Mn) Comparison, By Country 
            9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
            9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
            9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
            9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
            9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
            9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
     9.5. Revenue (US$ Mn) Comparison, By Route of Administration 
     9.6. Revenue (US$ Mn) Comparison, By Distribution Channel 
     9.7. Revenue (US$ Mn) Comparison, By Indication 

10. MEA Human Growth Hormone Market Size and Forecast, 2012-2026
     10.1. MEA Outlook 
     10.2. MEA Parent Market Outlook 
     10.3. MEA Target Market Outlook 
     10.4. Revenue (US$ Mn) Comparison, By Country 
            10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
            10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
            10.4.3. Nigeria Market Size and Forecast (US$ Mn), 2012-2026
            10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
     10.5. Revenue (US$ Mn) Comparison, By Route of Administration 
     10.6. Revenue (US$ Mn) Comparison, By Distribution Channel 
     10.7. Revenue (US$ Mn) Comparison, By Indication 

11. Global Human Growth Hormone Market Company Share, Competition Landscape and Company Profiles
     11.1. Company Share Analysis
     11.2. Competition Landscape
     11.3. Company Profiles
            11.3.1. Pfizer Inc.
            11.3.2. Merck KGaA
            11.3.3. Eli Lilly and Company
            11.3.4. Novo Nordisk A/S
            11.3.5. Novartis AG
            11.3.6. Ipsen S.A.
            11.3.7. Roche Holdings, Inc.
            11.3.8. Anhui Anke Biotechnology (Group) Co., Ltd
            11.3.9. Biopartners GmbH
            11.3.10. GeneScience Pharmaceuticals Co., Ltd

12. Research Methodology

13. Secondary and Primary Sources

14. Assumptions and Acronyms

15. Disclaimer

LIST OF TABLE

TABLE 1 Global Human Growth Hormone Market Value (US$ Mn), 2012-2017
TABLE 2 Global Human Growth Hormone Market Value (US$ Mn), 2018-2026
TABLE 3 Global Human Growth Hormone Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global Intravenous Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global Intravenous Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global Intravenous Segment Market Share, By Region 2012-2017
TABLE 7 Global Intravenous Segment Market Share, By Region 2018-2026
TABLE 8 Global Intravenous Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global Subcutaneous Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global Subcutaneous Segment Value (US$ Mn), By Region 2018-2026
TABLE 11 Global Subcutaneous Segment Market Share, By Region 2012-2017
TABLE 12 Global Subcutaneous Segment Market Share, By Region 2018-2026
TABLE 13 Global Subcutaneous Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global Intramuscular Segment Value (US$ Mn), By Region 2012-2017
TABLE 15 Global Intramuscular Segment Value (US$ Mn), By Region 2018-2026
TABLE 16 Global Intramuscular Segment Market Share, By Region 2012-2017
TABLE 17 Global Intramuscular Segment Market Share, By Region 2018-2026
TABLE 18 Global Intramuscular Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global Oral Segment Value (US$ Mn), By Region 2012-2017
TABLE 20 Global Oral Segment Value (US$ Mn), By Region 2018-2026
TABLE 21 Global Oral Segment Market Share, By Region 2012-2017
TABLE 22 Global Oral Segment Market Share, By Region 2018-2026
TABLE 23 Global Oral Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global Hospital Pharmacy Segment Value (US$ Mn), By Region 2012-2017
TABLE 25 Global Hospital Pharmacy Segment Value (US$ Mn), By Region 2018-2026
TABLE 26 Global Hospital Pharmacy Segment Market Share, By Region 2012-2017
TABLE 27 Global Hospital Pharmacy Segment Market Share, By Region 2018-2026
TABLE 28 Global Hospital Pharmacy Segment Y-o-Y, By Region 2017-2026
TABLE 29 Global Retail Pharmacy Segment Value (US$ Mn), By Region 2012-2017
TABLE 30 Global Retail Pharmacy Segment Value (US$ Mn), By Region 2018-2026
TABLE 31 Global Retail Pharmacy Segment Market Share, By Region 2012-2017
TABLE 32 Global Retail Pharmacy Segment Market Share, By Region 2018-2026
TABLE 33 Global Retail Pharmacy Segment Y-o-Y, By Region 2017-2026
TABLE 34 Global Online Pharmacy Segment Value (US$ Mn), By Region 2012-2017
TABLE 35 Global Online Pharmacy Segment Value (US$ Mn), By Region 2018-2026
TABLE 36 Global Online Pharmacy Segment Market Share, By Region 2012-2017
TABLE 37 Global Online Pharmacy Segment Market Share, By Region 2018-2026
TABLE 38 Global Online Pharmacy Segment Y-o-Y, By Region 2017-2026
TABLE 39 Global Clinics Segment Value (US$ Mn), By Region 2012-2017
TABLE 40 Global Clinics Segment Value (US$ Mn), By Region 2018-2026
TABLE 41 Global Clinics Segment Market Share, By Region 2012-2017
TABLE 42 Global Clinics Segment Market Share, By Region 2018-2026
TABLE 43 Global Clinics Segment Y-o-Y, By Region 2017-2026
TABLE 44 Global Growth Hormone Deficiency Segment Value (US$ Mn), By Region 2012-2017
TABLE 45 Global Growth Hormone Deficiency Segment Value (US$ Mn), By Region 2018-2026
TABLE 46 Global Growth Hormone Deficiency Segment Market Share, By Region 2012-2017
TABLE 47 Global Growth Hormone Deficiency Segment Market Share, By Region 2018-2026
TABLE 48 Global Growth Hormone Deficiency Segment Y-o-Y, By Region 2017-2026
TABLE 49 Global Turner Syndrome Segment Value (US$ Mn), By Region 2012-2017
TABLE 50 Global Turner Syndrome Segment Value (US$ Mn), By Region 2018-2026
TABLE 51 Global Turner Syndrome Segment Market Share, By Region 2012-2017
TABLE 52 Global Turner Syndrome Segment Market Share, By Region 2018-2026
TABLE 53 Global Turner Syndrome Segment Y-o-Y, By Region 2017-2026
TABLE 54 Global Idiopathic Short Stature Segment Value (US$ Mn), By Region 2012-2017
TABLE 55 Global Idiopathic Short Stature Segment Value (US$ Mn), By Region 2018-2026
TABLE 56 Global Idiopathic Short Stature Segment Market Share, By Region 2012-2017
TABLE 57 Global Idiopathic Short Stature Segment Market Share, By Region 2018-2026
TABLE 58 Global Idiopathic Short Stature Segment Y-o-Y, By Region 2017-2026
TABLE 59 Global Prader-Willi Syndrome Segment Value (US$ Mn), By Region 2012-2017
TABLE 60 Global Prader-Willi Syndrome Segment Value (US$ Mn), By Region 2018-2026
TABLE 61 Global Prader-Willi Syndrome Segment Market Share, By Region 2012-2017
TABLE 62 Global Prader-Willi Syndrome Segment Market Share, By Region 2018-2026
TABLE 63 Global Prader-Willi Syndrome Segment Y-o-Y, By Region 2017-2026
TABLE 64 Global Other Indications Segment Value (US$ Mn), By Region 2012-2017
TABLE 65 Global Other Indications Segment Value (US$ Mn), By Region 2018-2026
TABLE 66 Global Other Indications Segment Market Share, By Region 2012-2017
TABLE 67 Global Other Indications Segment Market Share, By Region 2018-2026
TABLE 68 Global Other Indications Segment Y-o-Y, By Region 2017-2026
TABLE 69 North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 70 North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 71 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 72 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 73 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 74 North America Human Growth Hormone Market Value (US$ Mn), By Country 2012-2017
TABLE 75 North America Human Growth Hormone Market Value (US$ Mn), By Country 2018-2026
TABLE 76 North America Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2012-2017
TABLE 77 North America Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2018-2026
TABLE 78 North America Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 79 North America Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 80 North America Human Growth Hormone Market Value (US$ Mn), By Indication 2012-2017
TABLE 81 North America Human Growth Hormone Market Value (US$ Mn), By Indication 2018-2026
TABLE 82 Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 83 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 84 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 85 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 86 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 87 Latin America Human Growth Hormone Market Value (US$ Mn), By Country 2012-2017
TABLE 88 Latin America Human Growth Hormone Market Value (US$ Mn), By Country 2018-2026
TABLE 89 Latin America Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2012-2017
TABLE 90 Latin America Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2018-2026
TABLE 91 Latin America Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 92 Latin America Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 93 Latin America Human Growth Hormone Market Value (US$ Mn), By Indication 2012-2017
TABLE 94 Latin America Human Growth Hormone Market Value (US$ Mn), By Indication 2018-2026
TABLE 95 Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 96 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 97 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 98 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 99 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 100 Europe Human Growth Hormone Market Value (US$ Mn), By Country 2012-2017
TABLE 101 Europe Human Growth Hormone Market Value (US$ Mn), By Country 2018-2026
TABLE 102 Europe Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2012-2017
TABLE 103 Europe Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2018-2026
TABLE 104 Europe Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 105 Europe Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 106 Europe Human Growth Hormone Market Value (US$ Mn), By Indication 2012-2017
TABLE 107 Europe Human Growth Hormone Market Value (US$ Mn), By Indication 2018-2026
TABLE 108 Japan Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 109 Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 110 Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 111 Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 112 Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 113 Japan Human Growth Hormone Market Value (US$ Mn), By Country 2012-2017
TABLE 114 Japan Human Growth Hormone Market Value (US$ Mn), By Country 2018-2026
TABLE 115 Japan Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2012-2017
TABLE 116 Japan Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2018-2026
TABLE 117 Japan Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 118 Japan Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 119 Japan Human Growth Hormone Market Value (US$ Mn), By Indication 2012-2017
TABLE 120 Japan Human Growth Hormone Market Value (US$ Mn), By Indication 2018-2026
TABLE 121 APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 122 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 123 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 124 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 125 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 126 APEJ Human Growth Hormone Market Value (US$ Mn), By Country 2012-2017
TABLE 127 APEJ Human Growth Hormone Market Value (US$ Mn), By Country 2018-2026
TABLE 128 APEJ Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2012-2017
TABLE 129 APEJ Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2018-2026
TABLE 130 APEJ Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 131 APEJ Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 132 APEJ Human Growth Hormone Market Value (US$ Mn), By Indication 2012-2017
TABLE 133 APEJ Human Growth Hormone Market Value (US$ Mn), By Indication 2018-2026
TABLE 134 MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 135 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 136 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 137 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 138 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 139 MEA Human Growth Hormone Market Value (US$ Mn), By Country 2012-2017
TABLE 140 MEA Human Growth Hormone Market Value (US$ Mn), By Country 2018-2026
TABLE 141 MEA Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2012-2017
TABLE 142 MEA Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2018-2026
TABLE 143 MEA Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 144 MEA Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 145 MEA Human Growth Hormone Market Value (US$ Mn), By Indication 2012-2017
TABLE 146 MEA Human Growth Hormone Market Value (US$ Mn), By Indication 2018-2026

LIST OF FIGURE

FIG. 1 Global Human Growth Hormone Market Value (US$ Mn), 2012-2017
FIG. 2 Global Human Growth Hormone Market Value (US$ Mn) Forecast, 2018-2026
FIG. 3 Global Human Growth Hormone Market Value (US$ Mn) and Y-o-Y, 2017-2026
FIG. 4 Global Intravenous Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 5 Global Intravenous Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 6 Global Intravenous Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7 Global Subcutaneous Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 8 Global Subcutaneous Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 9 Global Subcutaneous Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10 Global Intramuscular Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 11 Global Intramuscular Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 12 Global Intramuscular Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 13 Global Oral Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 14 Global Oral Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 15 Global Oral Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 16 Global Hospital Pharmacy Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 17 Global Hospital Pharmacy Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 18 Global Hospital Pharmacy Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 19 Global Retail Pharmacy Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 20 Global Retail Pharmacy Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 21 Global Retail Pharmacy Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 22 Global Online Pharmacy Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 23 Global Online Pharmacy Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 24 Global Online Pharmacy Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 25 Global Clinics Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 26 Global Clinics Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 27 Global Clinics Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 28 Global Growth Hormone Deficiency Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 29 Global Growth Hormone Deficiency Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 30 Global Growth Hormone Deficiency Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 31 Global Turner Syndrome Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 32 Global Turner Syndrome Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 33 Global Turner Syndrome Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 34 Global Idiopathic Short Stature Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 35 Global Idiopathic Short Stature Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 36 Global Idiopathic Short Stature Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 37 Global Prader-Willi Syndrome Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 38 Global Prader-Willi Syndrome Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 39 Global Prader-Willi Syndrome Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 40 Global Other Indications Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 41 Global Other Indications Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 42 Global Other Indications Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 43 North America Human Growth Hormone Market Value (US$ Mn), By Country 2012-2017
FIG. 44 North America Human Growth Hormone Market Value (US$ Mn), By Country 2018-2026
FIG. 45 North America Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2012-2017
FIG. 46 North America Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2018-2026
FIG. 47 North America Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 48 North America Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 49 North America Human Growth Hormone Market Value (US$ Mn), By Indication 2012-2017
FIG. 50 North America Human Growth Hormone Market Value (US$ Mn), By Indication 2018-2026
FIG. 51 Latin America Human Growth Hormone Market Value (US$ Mn), By Country 2012-2017
FIG. 52 Latin America Human Growth Hormone Market Value (US$ Mn), By Country 2018-2026
FIG. 53 Latin America Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2012-2017
FIG. 54 Latin America Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2018-2026
FIG. 55 Latin America Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 56 Latin America Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 57 Latin America Human Growth Hormone Market Value (US$ Mn), By Indication 2012-2017
FIG. 58 Latin America Human Growth Hormone Market Value (US$ Mn), By Indication 2018-2026
FIG. 59 Europe Human Growth Hormone Market Value (US$ Mn), By Country 2012-2017
FIG. 60 Europe Human Growth Hormone Market Value (US$ Mn), By Country 2018-2026
FIG. 61 Europe Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2012-2017
FIG. 62 Europe Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2018-2026
FIG. 63 Europe Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 64 Europe Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 65 Europe Human Growth Hormone Market Value (US$ Mn), By Indication 2012-2017
FIG. 66 Europe Human Growth Hormone Market Value (US$ Mn), By Indication 2018-2026
FIG. 67 Japan Human Growth Hormone Market Value (US$ Mn), By Country 2012-2017
FIG. 68 Japan Human Growth Hormone Market Value (US$ Mn), By Country 2018-2026
FIG. 69 Japan Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2012-2017
FIG. 70 Japan Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2018-2026
FIG. 71 Japan Human Growth Hormone Market Value (US$ Mn), By Indication 2012-2017
FIG. 72 Japan Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 73 Japan Human Growth Hormone Market Value (US$ Mn), By Indication 2012-2017
FIG. 74 Japan Human Growth Hormone Market Value (US$ Mn), By Indication 2018-2026
FIG. 75 APEJ Human Growth Hormone Market Value (US$ Mn), By Country 2012-2017
FIG. 76 APEJ Human Growth Hormone Market Value (US$ Mn), By Country 2018-2026
FIG. 77 APEJ Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2012-2017
FIG. 78 APEJ Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2018-2026
FIG. 79 APEJ Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 80 APEJ Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 81 APEJ Human Growth Hormone Market Value (US$ Mn), By Indication 2012-2017
FIG. 82 APEJ Human Growth Hormone Market Value (US$ Mn), By Indication 2018-2026
FIG. 83 MEA Human Growth Hormone Market Value (US$ Mn), By Country 2012-2017
FIG. 84 MEA Human Growth Hormone Market Value (US$ Mn), By Country 2018-2026
FIG. 85 MEA Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2012-2017
FIG. 86 MEA Human Growth Hormone Market Value (US$ Mn), By Route of Administration 2018-2026
FIG. 87 MEA Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 88 MEA Human Growth Hormone Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 89 MEA Human Growth Hormone Market Value (US$ Mn), By Indication 2012-2017
FIG. 90 MEA Human Growth Hormone Market Value (US$ Mn), By Indication 2018-2026

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

228

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved